FMC Corp at Stephens Investor Conference Transcript
Well, I'm going to get us started, just so that we stay on schedule. So I'm Mark Connelly, I cover FMC, and I am very pleased to have both Pierre, CEO; and Mark Douglas, COO; as well as Mike Wherley with us today. FMC has been one of my favorite stocks to cover, which wasn't always true. When I was at Crédit Suisse, I didn't cover the stock because I couldn't figure it out. FMC used to be an incredibly diversified company as some of you know, with too many segments that we just literally couldn't figure out.
When FMC decided to split out the lithium business to stand on its own as Livent, and then DuPont comes along with the -- their forced sale of the diamides business that allowed FMC to also split up the nutrition and bio and then, boom, all of a sudden, you've gone from one of the most complicated chemical companies I had ever encountered, to a pure-play crop protection at a time when I had literally just written a report at my last job that said pesticides are the new GMOs that the world has
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |